Challenges in Predicting Future Costs for Metastatic Breast Cancer

Michaela A Dinan^{1

2}, Rachel A Greenup^{2

3}

Affiliations

¹ Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
² Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, CT, USA.
³ Department of Surgery (Oncology), Yale School of Medicine, New Haven, CT, USA.

Editorial

Michaela A Dinan et al. JNCI Cancer Spectr. 2021.

. 2021 Jul 13;5(4):pkab064.

doi: 10.1093/jncics/pkab064. eCollection 2021 Aug.

Michaela A Dinan^{1

2}, Rachel A Greenup^{2

3}

¹ Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA.
² Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale School of Medicine, New Haven, CT, USA.
³ Department of Surgery (Oncology), Yale School of Medicine, New Haven, CT, USA.

No abstract available

Comment on

Projecting the Prevalence and Costs of Metastatic Breast Cancer From 2015 through 2030.
Gogate A, Wheeler SB, Reeder-Hayes KE, Ekwueme DU, Fairley TL, Drier S, Trogdon JG. Gogate A, et al. JNCI Cancer Spectr. 2021 Jul 13;5(4):pkab063. doi: 10.1093/jncics/pkab063. eCollection 2021 Aug. JNCI Cancer Spectr. 2021. PMID: 34409255 Free PMC article.

1. Siegel RL, Miller KD, Jemal A.. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30. doi:10.3322/caac.21442 (2018). - DOI - PubMed
1. Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML.. Projections of the cost of cancer care in the United States: 2010-2020 [published online ahead of print January 12, 2011]. J Natl Cancer Inst. 2011;103(2):117–128. doi:10.1093/jnci/djq495. [Erratum in: J Natl Cancer Inst. 2011;103(8):699. PMID: 21228314; PMCID: PMC3107566. - PMC - PubMed
1. Chang S, Long SR, Kutikova L, et al.Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. J Clin Oncol. 2004;22(17):3524–3530. doi:10.1200/J Clin Oncol.2004.10.170. - PubMed
1. Trogdon JG, Baggett CD, Gogate A, et al.Medical costs associated with metastatic breast cancer in younger, midlife, and older women. Breast Cancer Res Treat. 2020;181(3):653–665. doi:10.1007/s10549-020-05654-x. - PMC - PubMed
1. Wan C, Williams CP, Nipp RD, et al.Treatment decision making and financial toxicity in women with metastatic breast cancer. Clin Breast Cancer. 2021;21(1):37–46. doi:10.1016/j.clbc.2020.07.002. - PubMed